232 related articles for article (PubMed ID: 24040060)
1. Actin cytoskeleton regulates Hippo signaling.
Reddy P; Deguchi M; Cheng Y; Hsueh AJ
PLoS One; 2013; 8(9):e73763. PubMed ID: 24040060
[TBL] [Abstract][Full Text] [Related]
2. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP.
Cheng Y; Feng Y; Jansson L; Sato Y; Deguchi M; Kawamura K; Hsueh AJ
FASEB J; 2015 Jun; 29(6):2423-30. PubMed ID: 25690654
[TBL] [Abstract][Full Text] [Related]
3. CD44 acts through RhoA to regulate YAP signaling.
Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
[TBL] [Abstract][Full Text] [Related]
4. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
5. Angiomotins link F-actin architecture to Hippo pathway signaling.
Mana-Capelli S; Paramasivam M; Dutta S; McCollum D
Mol Biol Cell; 2014 May; 25(10):1676-85. PubMed ID: 24648494
[TBL] [Abstract][Full Text] [Related]
6. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
7. Mutual regulation between Hippo signaling and actin cytoskeleton.
Matsui Y; Lai ZC
Protein Cell; 2013 Dec; 4(12):904-10. PubMed ID: 24248471
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Hippo signaling by actin remodeling.
Seo J; Kim J
BMB Rep; 2018 Mar; 51(3):151-156. PubMed ID: 29353600
[TBL] [Abstract][Full Text] [Related]
9. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).
Mo JS; Yu FX; Gong R; Brown JH; Guan KL
Genes Dev; 2012 Oct; 26(19):2138-43. PubMed ID: 22972936
[TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling.
Fan Q; Cheng Y; Chang HM; Deguchi M; Hsueh AJ; Leung PCK
Oncotarget; 2017 Apr; 8(16):27166-27176. PubMed ID: 28460443
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.
Regué L; Mou F; Avruch J
Bioessays; 2013 May; 35(5):430-5. PubMed ID: 23450633
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway polarizes the actin cytoskeleton during collective migration of Drosophila border cells.
Lucas EP; Khanal I; Gaspar P; Fletcher GC; Polesello C; Tapon N; Thompson BJ
J Cell Biol; 2013 Jun; 201(6):875-85. PubMed ID: 23733343
[TBL] [Abstract][Full Text] [Related]
16. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
17. Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma: impact on keratinocyte proliferation and stromal cell activation.
Quan T; Xu Y; Qin Z; Robichaud P; Betcher S; Calderone K; He T; Johnson TM; Voorhees JJ; Fisher GJ
Am J Pathol; 2014 Apr; 184(4):937-943. PubMed ID: 24485923
[TBL] [Abstract][Full Text] [Related]
18. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
[TBL] [Abstract][Full Text] [Related]
19. Jasplakinolide induces primary cilium formation through cell rounding and YAP inactivation.
Nagai T; Mizuno K
PLoS One; 2017; 12(8):e0183030. PubMed ID: 28797107
[TBL] [Abstract][Full Text] [Related]
20. Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice.
Morikawa Y; Zhang M; Heallen T; Leach J; Tao G; Xiao Y; Bai Y; Li W; Willerson JT; Martin JF
Sci Signal; 2015 May; 8(375):ra41. PubMed ID: 25943351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
